E-LIB Suche - Ergebnisse für: Nicola Polverelli, MD

1

Busulfan or Treosulfan Conditioning Platform for Allogeneic..:

Michele Malagola, MD ; Nicola Polverelli, MD ; Massimo Martino, MD...
http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001451. , 2023

Link: https://doi.org/10.1097/..

2

Allogeneic haematopoietic cell transplantation for advanced..:

McLornan, Donal P. ; Czerw, Tomasz ; Damaj, Gandhi...
Leukemia. 38 (2024) 4 - p. 699-711 , 2024

Link: https://doi.org/10.1038/..

3

Treosulfan compared to busulfan in allogeneic haematopoieti..:

Robin, Marie ; Iacobelli, Simona ; Koster, Linda...
Bone Marrow Transplantation. 59 (2024) 7 - p. 928-935 , 2024

Link: https://doi.org/10.1038/..

4

Indication and management of allogeneic haematopoietic stem..:

Kröger, Nicolaus ; Bacigalupo, Andrea ; Barbui, Tiziano...
The Lancet Haematology. 11 (2024) 1 - p. e62-e74 , 2024

Link: https://doi.org/10.1016/..

5

Donor Lymphocyte Infusion in the Treatment of Post-Transpla..:

Accorsi Buttini, Eugenia ; Doran, Cristina ; Malagola, Michele...
Cancers. 16 (2024) 7 - p. 1278 , 2024

Link: https://doi.org/10.3390/..

6

Epidemiology and disease characteristics of myelofibrosis: ..:

Breccia, Massimo ; Palandri, Francesca ; Polverelli, Nicola...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

7

Prednisone vs high-dose dexamethasone in newly diagnosed ad..:

Mazzucconi, Maria Gabriella ; Rodeghiero, Francesco ; Avvisati, Giuseppe...
Blood Advances. 8 (2024) 6 - p. 1529-1540 , 2024

Link: https://doi.org/10.1182/..

8

Impact of comorbidities and body mass index on the outcomes..:

Polverelli, Nicola ; Bonneville, Edouard F. ; de Wreede, Liesbeth C....
American Journal of Hematology. 99 (2024) 5 - p. 993-996 , 2024

Link: https://doi.org/10.1002/..

9

Correction: Treosulfan compared to busulfan in allogeneic h..:

Robin, Marie ; Iacobelli, Simona ; Koster, Linda...
Bone Marrow Transplantation. 59 (2024) 8 - p. 1205-1205 , 2024

Link: https://doi.org/10.1038/..

10

P1028: MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX) MO..:

Palandri, Francesca ; Auteri, Giuseppe ; Iurlo, Alessandra...
HemaSphere. 7 (2023) S3 - p. e4692509 , 2023

Link: https://doi.org/10.1097/..

11

MPN-193 Incidence of Blast Phase in Myelofibrosis According..:

Mora, Barbara ; Maffioli, Margherita ; Rumi, Elisa...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S386-S387 , 2023

Link: https://doi.org/10.1016/..

12

Successful CAR-T cell therapy in a refractory MCL patient w..:

Radici, Vera ; Giagulli, Cinzia ; Accorsi Buttini, Eugenia...
Frontiers in Transplantation. 2 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

13

Updates on accelerated and blast phase myeloproliferative n..:

Mahdi, Dina ; Spiers, Jessica ; Rampotas, Alexandros..
British Journal of Haematology. 203 (2023) 2 - p. 169-181 , 2023

Link: https://doi.org/10.1111/..

14

Bone marrow CD34+ molecular chimerism as an early predictor..:

Malagola, Michele ; Polverelli, Nicola ; Beghin, Alessandra...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

15

PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLE..:

Bernardi, Simona ; Farina, Mirko ; Re, Federica...
HemaSphere. 7 (2023) S3 - p. e4289079 , 2023

Link: https://doi.org/10.1097/..